肺癌临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 肺癌（国际通用名 lung cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖肺腺癌、肺鳞癌、非小细胞肺癌、NSCLC、小细胞肺癌等说法。

正在招募的肺癌新药试验

• IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy

  不适用招募中法国NCT07608835

• Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia

  不适用招募中澳大利亚意大利NetherlandsSwitzerlandNCT06166706

• Pembrolizumab for Advanced NSCLC and PS 2-3

  II 期招募中美国NCT05589818

• Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.

  III 期招募中中国NCT07443397

• A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  I 期 / II 期招募中美国Puerto RicoNCT07109726

• Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

  不适用招募中中国NCT06818149

• Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

  I 期 / II 期招募中BelgiumNCT05765084

• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  I 期 / II 期招募中美国日本NCT07488676

• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

  I 期招募中LebanonNCT06307249

• Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer

  I 期招募中中国NCT05979818

• A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  II 期招募中美国NCT07154290

• Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study

  不适用招募中意大利NCT07042724